Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of "standard of care" plus quinine sulfate. "Standard of care" refers to the best-known treatment regimen for a particular disease, which may vary depending on the indication and local guidelines. Quinine sulfate is an antimalarial small molecule that acts by interfering with the parasite's ability to digest hemoglobin, leading to its death. It is primarily used in combination with antibiotics such as doxycycline, tetracycline, or clindamycin for the treatment of uncomplicated malaria caused by Plasmodium falciparum, especially in cases resistant to chloroquine[1][5][6]. The mechanism involves inhibition of heme polymerase activity in Plasmodium species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on standard of care + quinine sulfate.